The meaning of Yuan Lao's research is to let the Chinese people avoid hunger as much as possible, and at the same time, it also provides a possibility for hundreds of millions of people who are still starving.

And Wu Zhou's company means to make people eat better.

The value of Yuan Lao is far from what Wu Zhou is doing at the moment, which is why countless netizens jokingly call Yuan Lao the contemporary god of agriculture.

This set of flexible exoskeletons is a work that came in a 'hurry', after all, according to the future time, Yuan Lao may be careless next

Therefore, seeing that the time was getting closer and closer, Wu Zhou went directly to the laboratory, got the flexible electrotransformable materials, and then arbitrarily 'finalized' a number of test directions, so that the landing time of the product was greatly advanced.

However, even if the relevant technical problems have been solved, it will take some time for industrial mass production.

After Wu Zhou returned to Cloud City, he returned directly to the company, and the New Year was about to be celebrated.

The company is making the final financial accounting and year-end plan.

Some high-level officials suggested that they could hold an internal party or something to enliven the atmosphere, but Wu Zhou gave it a no.

"Now in this situation, the annual meeting, the crowd is too dense, very unsafe, and the annual meeting is actually of little significance, employees are not happy in the company, can they continue to work, the focus is not whether the annual meeting is good, the main thing is whether the work is happy or not, and whether the salary is enough, so there is the money for the annual meeting, it is better to send it directly to the employees." Wu Zhou made the final decision.

A lot of unexpected things happened in 2020.

Even Wu Zhou himself didn't expect this year's development to reach such a point.

Conventional products, Qiao Fei's snacks, and fast food have ushered in continuous hot sales from the beginning of the year to the end of the yearUnder the premise of a huge base, some products still bring several times, or even dozens of times of high growth.

And masks, this rigid demand product, has always been in short supply, even if the foreign side is liberalized in the later stage, but the sales of masks have not changed, tens of billions of masks, through various paths, into the world, half of which are sold abroad.

To the medical equipment produced by the company, tens of thousands of hospitals and tens of millions of patients have used Aiying Medical's oxygen concentrators, which has won more vitality for them.

Up to now, the machine failure feedback has also proved the quality of the product, so that the medical staff of major hospitals have realized that the quality of Aiying Medical products is reliable and excellent.

Then there is the world's first marketed 'mask vaccine'.

This social significance is very great, and it has also brought a lot of economic benefits to Wu Zhou.

And finally, Wu Zhou's newly established Aiying Technology released a work that 'shocked' the world, Drawing Dream AI, which once again detonated the global topic and overwhelmed the limelight of this vaccine

In the eyes of the outside world, Wu Zhou has never been on the hot search from beginning to end in 2020.

His net worth, in the news, has also changed from the youngest billionaire at the beginning, to a billionaire, and finally became unknown

In addition to this, there are a few more titles.

"Miracle Worker"

"The guardian of global human health."

"The Entrepreneur Who Changed the World"

"Technology leader leading the next generation of AI"

and "Heaven's Darling"

And then

Many bigwigs even ask about Wu Zhou more or less when they are interviewed by the media in public.

In this way, it can bring a lot of heat.

Of course, the positive image in China is 'deep-rooted', but in the foreign media, it is diametrically opposed.

Originally, because the company was a Chinese enterprise, it would naturally be disliked by many 'consumers', and Wu Zhou's masks earned a lot of profits.

Finally, Aiying Biotech's vaccine was launched, becoming the world's first related vaccine to be marketed.

It is important to know that during the same period, there were more than 200 related vaccine projects under development in the world, and only 15 of them were in the stage of human clinical trials.

But in the end, the fastest progress was actually Wu Zhou's Aiying Biology.

The two biopharmaceutical companies in the United States are also speeding up the progress of the vaccine market, but at the last moment, the relevant leaders were exposed and accepted bribes from pharmaceutical companies, and the vaccines of the two pharmaceutical companies had serious side effects when conducting human experiments, and there were major safety risks.

After this news was exposed, although it was quickly reported simultaneously around the world, a few hours later, the mainstream media and Internet platforms on Omi's side took the relevant news off the shelves.

That is, after all, there are not only Omi in the world, they only account for about 15% of the world's population, and the people of other countries saw the news, and then, all their hopes fell on Wu Zhou's Aiying Biotechnology.

In only about 2 days, the media on Omi's side exposed that Aiying Biotech's inactivated vaccine also had serious side effects and a significant unknown risk.

But the news was only on the 'hot search' on the Omi side, because some netizens predicted the prediction of Omi's side in advance, and explained in advance that Omi would definitely issue similar news to slander the reputation of Huaxia Aiying biological vaccine, and then create news, and in the news, no conclusive evidence will be given, just hypotheses and inferred conclusions.

This remark was mixed in with previous comments about the vaccine scandal on Omi's side.

Of course, there is an inference in addition to this.

"Although the news has exposed the safety risks of these vaccines, the market for this vaccine is very huge, and as the largest biopharmaceutical company on the side of Omi, the vaccine will definitely be on the market in the end, just sooner or later."

"Isn't it true that there are a lot of vaccines in the world that are being tested on humans?"

"But at present, only the vaccine from Huaxia has succeeded, and the closest to success on the Omi side has been, and in addition, the vaccines of other countries are not small."

"Okay, understood, with the Huaxia vaccine."

Of course, there are also some public figures in Huaxia who are cynical about domestic vaccines, and compare imported products with domestic products, which is self-evident.

However, no amount of cynicism can be worth the fact that there are probably and only Aiying Biotech's vaccines on the market.

Either those hard-mouthed people will wait for the imported vaccine in their minds to be produced and then shot, or pinch their noses and use the vaccine of Aiying Biotech.

In more than 200 countries and regions around the world, the vaccines that really have the strength to research are actually a few of the few, and because it is a 'single vaccine', Aiying's vaccine has been sought after by most countries around the world.

Aiying's related vaccine production line is in full swing.

The export of related technologies is also selectively exported as products or a complete set of technologies under the guidance of the state.

However, during that time, Aiying Biotech was hot after speculation, but Wu Zhou had been busy with Aiying Technology.

The technical superiority of Drawing Dream AI has also made many ordinary people who were originally skeptical of 'Aiying Biotech' have a sense of trust in such a little-known company as Aiying Biotech.

By the time 2020 has passed, Aiying Biotech's vaccine orders have reached 700 million, of which 500 million are supplied at an average price of about 50 yuan in China, 200 million are supported abroad, and the price of a single vaccine is 200 yuan, with a total payment amount of 65 billion.

The estimated gross profit is about 50 billion.

At the beginning, the purchase of related biomedical companies + medical device companies was only about 25 billion yuan, plus Wu Zhou's large R&D investment in the later stage, poaching people and a series of other measures, Mao's estimate was less than 10 billion.

After coming and going, Wu Zhou's investment of less than 35 billion yuan has been paid back in less than a year, and he has earned 15 billion + excess profits, of course, these are gross calculations, and there are many tax aspects that have not been carefully calculated.

And it is not surprising that in 2021, Aiying Biotech's revenue and profit may rise to a new level, and the important thing is that the capital will come back in 2020.

This TMD, this proper money printing machine

Of course, although this is enough to make people blush, this is only one of Wu Zhou's revenues in 2020, and it is only a small part

The biggest mask is sold from the beginning of the year to the end of the year, which has been selling well and is in short supply almost all year round.

A total of more than 100 billion pieces were sold, bringing 138.1 billion revenue to the company

Because the overseas supply was completely short of demand in the early stage, the masks were out of stock worldwide, and the 'US dollar' was used as the settlement currency, which brought a direct ultra-high premium, and then this profit reached an outrageous and unrepeatable 98.1 billion.

Finally, it has always been the main business of Aiying Group.

Big foods include snacks, fast food, etc., online and offline, because of the wealth, because of the popularity, this year, the products of Aiying Group have been fully rolled out across the country, and even the general small county supermarkets and convenience stores in small towns can see related products.

As a direct result of this, the total revenue reached 78.1 billion.

In addition to masks, the department store has a total revenue of 8.2 billion, as well as 1.9 billion for mothers and children, with a total sales of 88.2 billion and a profit of 39.3 billion.

Finally, medical equipment such as oxygen concentrators, air disinfection purifiers, fresh fans, virus detectors, etc., with a total of 32.8 billion sold and a profit of 13.5 billion.

In general, Wu Zhou's company, excluding Aiying Technology, has a total revenue of 324.1 billion, a total profit of 200.9 billion, and a gross profit margin of 61.99%. (Aiying Technology is counted separately, because although this company is named Aiying, most of it is actually Wu Zhou's own pocket and the cooperation with Juchang)

(End of chapter)